McKesson (MCK -1.2%) says it's received notification of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act in connection with its proposed acquisition of PSS World Medical (PSSI +1.3%). The termination of the waiting period is just one of the obstacles it needs to hurdle in it's proposed acquisition of PSS World Medical.
Shares of athenahealth (ATHN -2.1%) dip on the back of today's earlier announcement that PSS Worldwide (PSSI +33%) had agreed to be acquired by McKesson (MCK +4%). PSSI currently sells ATHN's services to physicians, and investors appear to be concerned that the relationship is likely to be derailed over the long-term, despite MCK's assertion that it doesn't plan to immediately "distort or dismantle" any of PSS's relationships "without careful evaluation."
PSS World Medical (PSSI) jumps 33% to $28.66 on news that McKesson (MCK) is acquiring the company for $29 a share, valuing it at $1.46B. McKesson plans to combine its medical surgical ops with those of PSS to offer medical supplies and other services. McKesson expects annual synergies of $100M by the fourth year after closure.
Medical distributor PSS World Medical (PSSI -1%) dips after short-selling blog TheStreetSweeper.com quoted an unnamed doctor as saying that the company's plan to reinvent itself is an "act of pure desperation," adding that the company is loaded with debt and Wall Street analysts "seem a bit skeptical" about the plan. Additionally, forensic accountant Keith Mautner, recently reviewed its financial documents and noted some discrepancies, saying "It wouldn't surprise me if the company was trying to hide something."
PSS World Medical (PSSI -0.3%) says it's sold its specialty dental business to Beecken Petty O'Keefe & Company for $68M. The transaction is expected to close in October 2012, and the company plans to use the funds from the sale to grow its physician, laboratory, dispensing and home care & hospice units.
PSI Worldwide (PSSI +7%) pops this morning after management cancels its roadshow, leaving traders to speculate on a potential buyout. Options activity shows above average volume in the front month calls as well, which generally indicates speculative takeover activity.
PSS World Medical (PSSI -5.4%) slips after missing FQ4 results across the board this morning. Additionally, the company's Board of Directors has approved a strategic restructuring plan to divest itself of certain assets and focus its efforts and investments on what it believes will be the fastest growing segments of its business. Raymond James downgraded the shares on the back of the announcement and poor results.